Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: The swedish experience and standpoint

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 1881-1883

  Hirvikoski, Tatja ^a   Nordenstrm, Anna ^a   Wedell, Anna ^a   Ritzn, Martin ^a   Lajic, Svetlana ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; CLINICAL TRIAL (TOPIC); CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GONADAL DISEASE; HUMAN; MALE; MULTICENTER STUDY (TOPIC); PREGNANCY; PRENATAL EXPOSURE; RISK FACTOR; SWEDEN;

ADRENAL HYPERPLASIA, CONGENITAL; CLINICAL TRIALS AS TOPIC; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SWEDEN; VIRILISM;

EID: 84864914283     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1222     Document Type: Article

References (11)

1. NimkarnS, NewMI2007Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat Clin Pract Endocrinol Metab3:405–413
2. MillerWL1999Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol162:537–540
3. SecklJR2004Prenatal glucocorticoids and long-term programming.Eur J Endocrinol151(Suppl 3):U49–U62
4. de VriesA, HolmesMC, HeijnisA, SeierJV, HeerdenJ, LouwJ, Wolfe-CooteS, MeaneyMJ, LevittNS, SecklJR2007Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest117:1058–1067
5. DalzielSR, WalkerNK, ParagV, MantellC, ReaHH, RodgersA, HardingJE2005Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet365:1856–1862
6. SpeiserPW, AzzizR, BaskinLS, GhizzoniL, HensleTW, MerkeDP, Meyer-BahlburgHF, MillerWL, Montori VM, Oberfield SE, Ritzen M, White PC 2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab95:4133–4160
7. HirvikoskiT, LindholmT, LajicS, Nordenström A 2011Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia—a pilot study. Acta Paediatr100:e112–e119
8. HirvikoskiT, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Lajic S2008 Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol159:309–316
9. HirvikoskiT, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S 2007 Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab92:542–548
10. LajicS, WedellA, BuiTH, Ritzén EM, Holst M 1998 Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab83:3872–3880
11. LWPES/ESPE2002Consensus statement on 21-hydroxylase deficiency from The Lawson Wilkins Paediatric Endocrine Society and The European Society for Paediatric Endocrinology.J Clin Endocrinol Metab87:4048–4053